Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
A carbohydrate called heparan sulfate, found on cell surfaces, may help the new coronavirus infects cells.
None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.
Black and Latino cancer patients have higher rates of coronavirus infection and hospitalization but are less likely to use telehealth.
The study represents the most comprehensive scientific survey to date about the interrelationship between COVID-19 and cancer.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
Survey shows coronavirus health care delays and anxiety persist for cancer patients and survivors months into pandemic.
The treatment reduced coronavirus levels and sped up recovery in a clinical trial.
Results appear on an easy-to-read strip that is akin to a pregnancy test, without the need for expensive or specialized lab equipment.
New findings may explain why some people with COVID-19 develop more severe disease.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A new CDC study leaves the question of indoor versus outdoor dining unanswered.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.